Year : 2018 | Volume
: 19 | Issue : 2 | Page : 45--48
Predictors of coronary artery disease progression among high-risk patients with recurrent symptoms
Iyad Farah1, Amjad M Ahmed1, Raed Odeh1, Eltayyeb Alameen1, May Al-Khateeb1, Elias Fadel1, Raid Rabai1, Dalia Ali1, Bassam Bdeir1, Mouaz H Al-Mallah2
1 King Abdulaziz Cardiac Center, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Kingdom of Saudi Arabia
2 King Abdulaziz Cardiac Center, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs; King Saud bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia
Background: Despite the availability of new potent medical therapies, the rate of progression of angiographic coronary artery disease (CAD) is not well described. The aim of this analysis is to describe the rate and predictors of progression of CAD among patients with recurrent symptoms.
Materials and Methods: We reviewed 259 patients (mean age 61 ± 11 years, 70% males) who underwent two coronary angiograms between 2008 and 2013. Progressive CAD was defined as obstructive CAD in a previously disease-free segment or new obstruction in a previously nonobstructive segment. Patients who had coronary artery bypass surgery between these two angiograms were excluded from the analysis. Multivariate logistic regression was used to determine the independent predictors of progression of CAD.
Results: The included cohort had a high prevalence of coronary risk factors; hypertension (71%), diabetes (69%), and dyslipidemia (75%). Despite adequate medical therapy, more than half of the patients (61%) had CAD progression. Using multivariate logistic regression, a drop in the left ventricular ejection fraction (LVEF) by more than 5% was the predictor of CAD progression (adjusted odds ratio 5.8, P = 0.042, 95% confidence interval 1.1–31.2).
Conclusion: Among high-risk patients with recurrent symptoms, the short-term rate of progression of CAD is high. A drop in LVEF >5% is a predictor of CAD progression. Further studies are needed to determine the prognostic value of CAD progression in the era of potent medical therapy.
Dr. Mouaz H Al-Mallah
King Abdulaziz Cardiac Center, King Abdulaziz Medical City for National Guard-Riyadh, Department Mail Code: 1413 P.O. Box 22490, Riyadh 11426
Kingdom of Saudi Arabia
|How to cite this article:|
Farah I, Ahmed AM, Odeh R, Alameen E, Al-Khateeb M, Fadel E, Rabai R, Ali D, Bdeir B, Al-Mallah MH. Predictors of coronary artery disease progression among high-risk patients with recurrent symptoms.Heart Views 2018;19:45-48
|How to cite this URL:|
Farah I, Ahmed AM, Odeh R, Alameen E, Al-Khateeb M, Fadel E, Rabai R, Ali D, Bdeir B, Al-Mallah MH. Predictors of coronary artery disease progression among high-risk patients with recurrent symptoms. Heart Views [serial online] 2018 [cited 2020 Apr 1 ];19:45-48
Available from: http://www.heartviews.org/article.asp?issn=1995-705X;year=2018;volume=19;issue=2;spage=45;epage=48;aulast=Farah;type=0